Benzinga's Top #PreMarket Losers

The ExOne Company XONE shares dropped 14.27% to $26.43 in pre-market trading after the company reported a wider first-quarter loss. The company posted a loss of $0.38 per share on revenue of $7.3 million. However, analysts were projecting a loss of $0.12 per share on revenue of $9.7 million. Incyte INCY dropped 10.11% to $50.25 in pre-market trading after abstract posted at ASCO. Diana Containerships DCIX shares fell 5.06% to $3.00 in pre-market trading. Euro Pacific Capital downgraded the stock from Buy to Neutral. Bristol-Myers Squibb Company BMY dipped 3.11% to $50.50 in pre-market trading as the company reported that nivolumab in combo with yervoy in Phase 2 and 1b trials showed anti-tumor activity. BMO Capital downgraded Bristol-Myers Squibb from Overweight to Market Perform and cut the price target from $60.00 to $55.00.